Asahi Kaisei Adr Stock Price, News & Analysis

Summary not available.

Asahi Kasei Pharma is inviting proposals for drug development research, offering funding of up to US$200,000 annually for selected applications over a period of 1-3 years. The application window runs from January 5, 2023 to February 28, 2023. The focus areas include autoimmune, renal, neurodegenerative, and bone diseases, alongside platform technologies for drug discovery. Established in 2016, Asahi Kasei Pharma has funded over 20 proposals and aims to foster innovation through collaborations with global researchers.

Asahi Kasei and Crystal IS have reported that their experimental Klaran™ WR UVC LED water treatment reactor outperformed traditional mercury lamp systems by over 75% in bacterial performance tests. The reactor operates at the same power level (6 W) while being lighter, smaller, and safer, contributing to a mercury-free environment. This advancement aligns with the stricter regulations following the Minamata Convention, promoting energy efficiency and safer water treatment. Asahi Kasei aims to replace mercury lamps with UVC LEDs in various applications.

Asahi Kasei is launching new grades of XYRON™ modified polyphenylene ether (mPPE) to enhance 5G applications in North America and Europe. These materials offer improved connectivity, lighter weight, and higher heat resistance than traditional metals. Key features include low dielectric permittivity and high hydrolysis resistance, resulting in better efficiency for 5G smartphone antennas and base stations. The new recycled PET/PPE alloys utilize 40% post-consumer materials, supporting sustainability. XYRON™ will be showcased at K 2022 in Düsseldorf from October 19-26.

Asahi Kasei has announced a trial to test its K-GIS zeolite adsorbent for purifying biogas at Kurashiki City's sewage treatment plant. The System aims to efficiently separate CO₂ from biogas, generating high-purity biomethane. Aiming for operational launch by the end of 2023, the project aligns with the company's carbon neutrality goals. The partnership with Kurashiki City emphasizes the importance of decarbonization. If effective, this technology could lead to a carbon-negative cycle through carbon capture, utilization, or storage.

Asahi Kasei will unveil its AKXY2 concept car at K 2022 in Düsseldorf, Germany, from October 19-26. This model showcases the company's advanced technology and sustainable materials, including innovative particle foams and bio-based fillers aimed at electric vehicles. Key materials on display include polycarbonates produced using CO2 as a raw material and premium microfiber Dinamica®. The AKXY2 also features cellulose-based materials and next-gen engineering plastics. Asahi Kasei emphasizes its commitment to sustainability and innovation across its diverse product portfolio.

Asahi Kasei Bioprocess America will showcase its MOTIV™ Buffer Management Technology at ACHEMA 2022 in Frankfurt, scheduled from August 22-26, 2022. This innovative system blends buffers from concentrates in small, single-use bags, significantly enhancing efficiency and precision in pharmaceutical production. It has received multiple accolades, including ‘Best in Show’ at Interphex 2017 and ‘Technology of the Decade’ from Bioprocess International in 2012. The system supports rapid and sustainable pharmaceutical manufacturing, allowing medicines to reach patients globally faster.

Summary not available.

Asahi Kasei has developed a new system for calculating the carbon footprint (CFP) of its synthetic rubber and elastomers products, which will start providing data to customers from June 2022. The system utilizes the DEEP group-wide management infrastructure for enhanced CFP visualization and reduction strategies. Asahi Kasei aims for carbon neutrality by 2050, incorporating sustainable practices like using butadiene derived from plastic waste. This system is crucial as regulations on carbon footprints increase, and it tailors data to meet customer requirements.